Skip to content

Nuclear Chemistry

Opportunities

Job

Researcher in Radionuclide Separation and Analytical Materials

Japan Atomic Energy Agency · Tokai, Japan

Closes

Mid-career staff recruitment in nuclear chemistry. Develop nanofunctional materials for radionuclide separation and analysis, investigate degradation under irradiation, and study material-surface responses involved in selective recognition. The work supports integrated analytical platforms and compact devices. The tentative assignment is at the Nuclear Science Research Institute in Tokai-mura, with appointment in principle after 1 April 2027. Applications close on 30 October 2026 at 17:00 Japan Standard Time.

From Chemistry

Grant

Royal Society Short Industry Fellowship — 2026 Round 2

Royal Society

Closes today

· Eligibility not stated

The Royal Society supports short exchanges between UK academia and industry to develop research collaborations. Fellowships last three to six months full-time, or up to twelve months at 50% part-time. Funding covers the salary of the applicant and/or a nominated postdoctoral researcher plus research expenses of up to £1,000. Applications for the second 2026 round close on 7 October 2026.

Grant

ACS PrepareCTP Grant

American Chemical Society

Closes today

· Eligibility not stated

Up to USD 20,000 for a one-year project at a US two-year college preparing chemical technical professionals. Projects can provide student stipends or scholarships, work-based learning, employer partnerships, equipment, instrumentation, curriculum development or faculty time to strengthen chemistry-related workforce pathways. Activities serving transfer-student populations are excluded. Applications opened 23 July and close 7 October 2026; the award period is January–December 2027, with project starts no later than 31 May. Submit through the official call’s linked grant platform, including project summary, narrative, budget, justification and personnel biosketches.

Conference

Highlights in Medicinal Chemistry VI

London, United Kingdom

Thu, Oct 8

Academic and industrial drug-discovery researchers will compare approaches that connect molecular mechanisms with development candidates. The programme examines targeted protein degradation, three-dimensional discovery strategies, oral coronavirus antivirals and fragment-derived IL17A inhibitors. Further talks address screening unpurified reaction mixtures, regulating innate immune cells, optimizing QPCT/L and PolQ inhibitors with computational and experimental expertise, measuring protein-interaction selectivity and designing covalent inhibitors. Programme participants include Angela Russell (University of Oxford); Anna Barnard (Imperial College, London); Mike Waring (University of Newcastle); James Johnson (UCB); Jens Willwacher (Boehringer Ingelheim); Ageo Miccoli (Sygnature). SCI’s Fine Chemicals Group hosts this in-person meeting at SCI, 14/15 Belgrave Square, London SW1X 8PS. On 8 October 2026, registration starts at 09:20, opening remarks at 09:50 and scientific talks at 09:55; closing remarks are at 17:05, followed by a 17:15 reception. Times are Europe/London, BST (UTC+01:00). Registration closes on 5 October. Current fees are £135 for SCI members, £170 for non-members, £70 for student members and £81 for unemployed members; discounted eligibility is checked by SCI. Use SCI’s Register Now link to sign in or continue with event registration.

New and updated

The Nuclear Chemistry Group at RIKEN’s Nishina Center for Accelerator-Based Science seeks one postdoctoral researcher, research scientist or senior research scientist to investigate superheavy elements. The researcher will perform nuclear chemistry studies at the RIKEN RI Beam Factory, maintain experimental chemistry apparatus and hot laboratories, and support collaborating researchers. A doctorate and expertise in nuclear and radiochemistry are required. Role level depends on research experience; the appointment is based at the Wako campus.

The Nuclear Chemistry Group at RIKEN’s Nishina Center for Accelerator-Based Science seeks one postdoctoral researcher, research scientist or Technical Staff I. The AMED cancer research project develops production and use of radioisotopes with the heavy-ion accelerators at the RIKEN RI Beam Factory. Researchers will develop isotope production and utilization techniques, investigate applications, distribute radioisotopes and maintain production equipment and hot laboratories. Technical staff will support production, quality evaluation and distribution, manage radioisotopes and chemicals, and support collaborating researchers. The appointment is based at Wako and requires experience handling unsealed radioisotopes.

Nearby fields

We use cookies for analytics.